Compare NVMI & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVMI | BAX |
|---|---|---|
| Founded | 1993 | 1931 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5B | 9.4B |
| IPO Year | 2000 | N/A |
| Metric | NVMI | BAX |
|---|---|---|
| Price | $326.49 | $19.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 10 |
| Target Price | ★ $307.00 | $25.67 |
| AVG Volume (30 Days) | 314.5K | ★ 8.2M |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 0.21% |
| EPS Growth | ★ 44.31 | N/A |
| EPS | ★ 7.71 | N/A |
| Revenue | $852,719,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $33.29 | $5.20 |
| Revenue Next Year | $9.67 | $2.02 |
| P/E Ratio | $40.97 | ★ N/A |
| Revenue Growth | ★ 39.37 | 3.90 |
| 52 Week Low | $154.00 | $17.40 |
| 52 Week High | $361.32 | $37.74 |
| Indicator | NVMI | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 53.71 | 58.18 |
| Support Level | $311.69 | $17.92 |
| Resistance Level | $338.35 | $19.17 |
| Average True Range (ATR) | 11.37 | 0.47 |
| MACD | 2.22 | 0.23 |
| Stochastic Oscillator | 75.64 | 94.95 |
Nova Ltd is a semiconductor equipment manufacturer. The company provides metrology solutions for process control used in semiconductor manufacturing. The company offers in-line optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems. The product range consists of Nova 2040, Nova 3090Next, Nova i500 and i500 Plus, Nova T500, Nova T600, Nova V2600, HelioSense 100, Nova Hybrid Metrology solution, NovaMars. The company generates the majority of its revenue from China. Geographically the company has its business spread across the region of Taiwan, Korea, China, the United States, and Europe.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.